Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
The Canadian Queer Chamber of Commerce Launches The FAM Program to Support 2SLGBTQI+ businesses and Entrepreneurs Nationwide
-
Enviri Corporation Reports Fourth Quarter and Full Year 2025 Results
-
Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream
-
New Publication Demonstrates Variant-Agnostic Correlate of Protection from COVID-19 for Invivyd Monoclonal Antibody, Useful for Understanding of and Confidence in COVID-19 Antibodies
-
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
-
Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)
-
Q2 Metals Discovers High Grade Zone with 170.2 Metre Intercept of 1.99% Li₂O, Including 40.1 m of 2.89% Li₂O at the Cisco Lithium Project
-
First Watch Restaurant Group, Inc. Reports 2025 Financial Results and Provides Outlook for 2026
-
Lahontan Drills High Grade Oxide Gold from the Surface at West Santa Fe: 37m Grading 3.11 g/t Au Eq Including 11m Grading 5.75 g/t Au Eq
-
EyePoint Announces Participation at Upcoming Investor Conferences
-
Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026
-
Ocular Therapeutix™ to Participate in March Investor Conferences
-
Ongwe Minerals Secures Additional Licenses, Significantly Increases Its Omatjete Project Area and Identifies Prospective Parallel Fault Zone
-
Garrett Motion Announces Participation at the Bank of America Global Automotive Summit
-
Atea Pharmaceuticals Presents Preclinical Results Supporting First-in-Class Potential of AT-587 for Treatment of Hepatitis E Virus at CROI 2026
-
Mobilicom to Participate at Enforce Tac 2026, Germany’s Prominent Trade Fair for Security and Defense
-
AMD and Meta Announce Expanded Strategic Partnership to Deploy 6 Gigawatts of AMD GPUs
-
Cipher Digital Provides Fourth Quarter and Full Year 2025 Business Update
-
Transcenta Therapeutics to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference
-
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
-
OROCO COMMENCES PHASE 2 DRILLING
-
Shoals Technologies Group, Inc. Reports Financial Results for Fourth Quarter 2025
-
Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
-
Iovance Biotherapeutics Highlights Strong Fourth Quarter and Full Year 2025 Results, Business Achievements and Corporate Updates
-
Axsome Therapeutics Initiates CLARITY Phase 3 Trial of Solriamfetol in Adults with Major Depressive Disorder with Excessive Daytime Sleepiness Symptoms
-
Shoals Technologies Group and ON.energy to Deploy Critical-Power Systems for Leading AI Data-Center Operator
-
Iovance Announces Positive Results from the First Clinical Trial for TIL Cell Therapy in Soft Tissue Sarcomas
-
Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
-
iBio to Participate in Upcoming Investor Conferences
-
Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook
-
Balchem Corporation to Participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026
-
Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
-
Abaxx Exchange Completes First Physical Delivery Under Gold Singapore Futures Contract
-
OTC Markets Group Welcomes GR Silver Mining Ltd. to OTCQX
-
OTC Markets Group Welcomes Dryden Gold Corp. to OTCQX
-
Aclaris Therapeutics Initiates Phase 1b Proof-of-Concept Trial in Patients with Asthma with its Novel Bispecific Anti-TSLP/IL-4Rα Antibody ATI-052
-
Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET
-
Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street
-
Avalo Therapeutics to Participate in Upcoming Investor Conferences
-
OTC Markets Group Welcomes Nations Royalty Corp. to OTCQX
-
Option Care Health Announces Financial Results for Fourth Quarter and Full Year 2025
-
Autolus Therapeutics to Participate in Upcoming Investor Conferences
-
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
-
AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor
-
Indivior to Participate in Upcoming Investor Conferences
-
Full year Trading Update and Notice of Results
-
OR Royalties Announces Acquisition of Additional Royalties on Spring Valley in Nevada
-
Amendment of the Liquidity Agreement with Kepler Cheuvreux
-
Form 8.3 - Picton Property Income Limited
-
YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
